International Journal of Colorectal Disease

, Volume 32, Issue 4, pp 453–458 | Cite as

Post-operative recurrence of Crohn’s disease after definitive stoma: an underestimated risk

  • Dine Koriche
  • Corinne Gower-Rousseau
  • Charbel Chater
  • Alain Duhamel
  • Julia Salleron
  • Noémie Tavernier
  • Jean-Frédéric Colombel
  • Benjamin Pariente
  • Antoine Cortot
  • Philippe Zerbib
Original Article



Crohn’s disease (CD) is a progressive inflammatory disease affecting the entire gastrointestinal tract. The need for a definitive stoma (DS) is considered as the ultimate phase of damage. It is often believed that the risk of further disease progression is small when a DS has been performed.


The goals of the study were to establish the rate of CD recurrence above the DS and to identify predictive factors of CD recurrence at the time of DS.


We retrospectively reviewed all medical records of consecutive CD patients having undergone DS between 1973 and 2010. We collected clinical data at diagnosis, CD phenotype, treatment, and surgery after DS and mortality. Stoma was considered as definitive when restoration of continuity was not possible due to proctectomy, rectitis, anoperineal lesions (APL), or fecal incontinence. Clinical recurrence (CR) was defined as the need for re-introduction or intensification of medical therapy, and surgical recurrence (SR) was defined as a need for a new intestinal resection.


Eighty-three patients (20 males, 63 females) with a median age of 34 years at CD diagnosis were included. The median time between diagnosis and DS was 9 years. The median follow-up after DS was 10 years. Thirty-five patients (42%) presented a CR after a median time of 28 months (2–211) and 32 patients (38%) presented a SR after a median time of 29 months (4–212). In a multivariate analysis, APL (HR = 5.1 (1.2–21.1), p = 0.03) and colostomy at time of DS (HR = 3.8 (1.9–7.3), p = 0.0001) were associated factors with the CR.


After DS for CD, the risk of clinical recurrence was high and synonymous with surgical recurrence, especially for patients with APL and colostomy.


Crohn’s disease Definitive stoma Colostomy 


  1. 1.
    Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001 Dec) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cosnes J1, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250CrossRefPubMedGoogle Scholar
  3. 3.
    Etienney I, Bouhnik Y, Gendre JP et al (2004) Crohn’s disease over 20 years after diagnosis in a referral population. Gastroenterol Clin Biol 28(12):1233–1239CrossRefPubMedGoogle Scholar
  4. 4.
    Bouguen G, Chevaux JB, Peyrin-Biroulet L (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol 17(5):547–556CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J et al (2014) Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 63(10):1607–1616CrossRefPubMedGoogle Scholar
  6. 6.
    Post S, Herfarth C, Schumacher H, Golling M, Schurmann G, Timmermanns G (1995) Experience with ileostomy and colostomy in Crohn’s disease. Br J Surg 82(12):1629–1633CrossRefPubMedGoogle Scholar
  7. 7.
    Coscia M, Gentilini L, Laureti S, Gionchetti P, Rizzello F, Campieri M et al (2013) Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Color Dis 15(9):1115–1122Google Scholar
  8. 8.
    Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME (2007) Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon rectum 50(12):2067–2074 15Google Scholar
  9. 9.
    Gooszen AW, Geelkerken RH, Hermans J, Lagaay MB, Gooszen HG (2000) Quality of life with a temporary stoma: ileostomy vs. colostomy. Dis Colon rectum 43(5):650–655Google Scholar
  10. 10.
    Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD (1999) Quality of life in stoma patients. Dis Colon rectum 42(12):1569–1574Google Scholar
  11. 11.
    Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG (2000) Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg 87(8):1063–1066CrossRefPubMedGoogle Scholar
  12. 12.
    Glotzer DJ, Stone PA, Patterson JF (1967) Prognosis after surgical treatment of granulomatous colitis. N Engl J Med 277(6):273–279CrossRefPubMedGoogle Scholar
  13. 13.
    Korelitz BI, Present DH, Alpert LI, Marshak RH, Janowitz HD (1972) Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med 287(3):110–115CrossRefPubMedGoogle Scholar
  14. 14.
    Ritchie JK (1990) The results of surgery for large bowel Crohn’s disease. Ann R Coll Surg Engl 72(3):155–157PubMedPubMedCentralGoogle Scholar
  15. 15.
    Vender RJ, Rickert RR, Spiro HM (1979) The outlook after total colectomy in patients with Crohn’s colitis and ulcerative colitis. J Clin Gastroenterol 1(3):209–217CrossRefPubMedGoogle Scholar
  16. 16.
    Goligher JC (1985) The long-term results of excisional surgery for primary and recurrent Crohn’s disease of the large intestine. Dis Colon rectum 28(1):51–55Google Scholar
  17. 17.
    Scammell BE, Andrews H, Allan RN, Alexander-Williams J, Keighley MR (1987) Results of proctocolectomy for Crohn’s disease. Br J Surg 74(8):671–674CrossRefPubMedGoogle Scholar
  18. 18.
    Yamamoto T, Allan RN, Keighley MR (2000) Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon rectum 43(2):249–256 16Google Scholar
  19. 19.
    Bernell O, Lapidus A, Hellers G (2001) Recurrence after colectomy in Crohn’s colitis. Dis Colon rectum 44(5):647–654Google Scholar
  20. 20.
    Amiot A, Gornet JM, Baudry C, Munoz-Bongrand N, Auger M, Simon M et al (2011) Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 43(9):698–702CrossRefPubMedGoogle Scholar
  21. 21.
    Steinberg DM, Allan RN, Thompson H, Brooke BN, Alexander-Williams J, Cooke WT (1974) Excisional surgery with ileostomy for Crohn’s colitis with particular reference to factors affecting recurrence. Gut 15(11):845–851CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ho I, Greenstein AJ, Bodian CA, Janowitz HD (1995) Recurrence of Crohn’s disease in end ileostomies. Inflamm Bowel Dis 1(3):173–178PubMedGoogle Scholar
  23. 23.
    Ecker KW, Gierend M, Kreissler-Haag D, Feifel G (2001) Reoperations at the ileostomy in Crohn’s disease reflect inflammatory activity rather than surgical stoma complications alone. Int J Color Dis 16(2):76–80CrossRefGoogle Scholar
  24. 24.
    Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F (2005) Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon rectum 48(5):963–969Google Scholar
  25. 25.
    Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J (2006) Predictors of Crohn’s disease. Gastroenterology 130(3):650–656CrossRefPubMedGoogle Scholar
  27. 27.
    Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231(1):38–45 17CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M et al (2009) Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136(2):441–450CrossRefPubMedGoogle Scholar
  29. 29.
    Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D (2010) Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol 8(7):591–599CrossRefPubMedGoogle Scholar
  30. 30.
    Sorrentino D (2013) State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 10(7):413–422CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Dine Koriche
    • 1
    • 2
  • Corinne Gower-Rousseau
    • 2
    • 3
  • Charbel Chater
    • 1
    • 2
  • Alain Duhamel
    • 4
  • Julia Salleron
    • 5
  • Noémie Tavernier
    • 6
  • Jean-Frédéric Colombel
    • 6
    • 7
  • Benjamin Pariente
    • 2
    • 6
  • Antoine Cortot
    • 6
  • Philippe Zerbib
    • 1
    • 2
  1. 1.Digestive Surgery and Transplantation Unit, Hôpital HuriezLille Nord de France University, Lille University Medical CenterLilleFrance
  2. 2.Lille Inflammation Research International Center LIRIC-UMR 995 InsermUniversité Lille 2/CHRU de Lille; Equipe « IBD and environmental factors: Epidemiology and functional analyses, Lille UniversityLilleFrance
  3. 3.Public Health, Epidemiology and Economic Health Unit, Registre Epimad, Maison Régionale de la Recherche CliniqueCentre Hospitalier Universitaire RégionalLille CedexFrance
  4. 4.Biostatistics Unit, EA2694Lille Nord de France University and Hospital, CHRULilleFrance
  5. 5.Unité de BiostatistiqueInstitut de Cancérologie de LorraineVandoeuvre lès NancyFrance
  6. 6.Hepatogastroenterology UnitLille Nord de France University, Lille University Medical CenterLilleFrance
  7. 7.Icahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations